GI
WX

GAMCO Investors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

GAMCO Investors’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-61,300
Closed -$2.65M – 842
2015
Q3 		$2.65M Buy
61,300
+7,100
+13% +$300K 0.02% 472
2015
Q2 		$2.29M Sell
54,200
-3,000
-5% -$127K 0.01% 505
2015
Q1 		$2.22M Hold
57,200
– – 0.01% 520
2014
Q4 		$1.93M Hold
57,200
– – 0.01% 537
2014
Q3 		$2M Hold
57,200
– – 0.01% 551
2014
Q2 		$1.88M Sell
57,200
-2,500
-4% -$85.6K 0.01% 551
2014
Q1 		$2.2M Sell
59,700
-5,500
-8% -$202K 0.01% 506
2013
Q4 		$2.5M Sell
65,200
-21,400
-25% -$676K 0.01% 483
2013
Q3 		$2.37M Sell
86,600
-30,500
-26% -$723K 0.01% 488
2013
Q2 		$2.46M Buy
+117,100
New +$2.29M 0.02% 459

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

GAMCO Investors's WX Position: Q4 2015 in Review

GAMCO Investors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 61,300 shares — an estimated $2.65M sold.

GAMCO Investors first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $2.65M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • GAMCO Investors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • GAMCO Investors sold 61,300 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.65M.
  • GAMCO Investors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • GAMCO Investors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.65M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on GAMCO Investors's 13F filing for Q4 2015, filed 5 Feb 2016.